Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

NCT00971763

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom
  • Leeds General Infirmary Leeds, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom
View Trial Details
Completed

Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma

NCT00660231

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Saint Bartholomew's Hospital London, England, United Kingdom
  • St. Thomas' Hospital London, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
View Trial Details
Completed

A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment

NCT01561911

Conditions
B-Cell, Cancer, Hemic and Lymphatic Diseases, +8 more
Locations
  • Cancer Research UK Institute for Cancer Studies, University of Birmingham Edgbaston, Birmingham, United Kingdom
  • Cancer Research UK Medical Oncology Unit, Southampton General Hospital Tremona Road,, Southampton, United Kingdom
View Trial Details
Completed

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

NCT00513955

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom
  • Good Hope Hospital Birmingham, England, United Kingdom
  • Birmingham Heartlands Hospital Birmingham, England, United Kingdom
  • Blackpool Victoria Hospital Blackpool, England, United Kingdom
View all 25 locations
View Trial Details
Completed

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

NCT00891137

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +59 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Loyola University Medical Center, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
View Trial Details
Completed

S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma

NCT00109928

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente - Fremont Fremont, California, United States
  • Kaiser Permanente Medical Center - Hayward Hayward, California, United States
View all 77 locations
View Trial Details

Related conditions